Community Trust ScoreVerified
Nasdaq began listing the Canary Staked INJ ETF under the ticker INJC on November 5, according to the exchange’s listing notice and Canary Capital. The product seeks exposure to INJ, the native token of the Injective network, while allowing investors to earn staking rewards.
Product Structure and Staking Mechanics
Injective operates a proof-of-stake blockchain. In such networks, eligible token holders can participate in network validation by delegating tokens to validators, a process that may generate rewards. The Canary Staked INJ ETF is designed to reflect these staking economics within its holdings and operations.
Canary Capital states that net staking rewards will be reflected in the ETF’s net asset value. The term “net” indicates that fund expenses, specific staking arrangements, validator performance, and timing can affect the final value delivered to shareholders. Consequently, the fund’s performance is subject to the operational choices of its service providers rather than direct control by individual investors.
The fund structure differs significantly from holding cryptocurrency in a self-custodied wallet. Ownership of the ETF shares does not equate to directly holding or controlling INJ tokens. The listed wrapper handles custody and operational decisions through fund service providers. Investors in the ETF cannot select their own validator, manage private keys, or participate directly in onchain governance.
Listing Details and Market Access
Nasdaq issued a trader notice on November 4 confirming that the listing would begin on Thursday, November 5. The notice identifies the designated liquidity provider and the start of trading and valuation dissemination. This confirmation serves as concrete evidence of the product’s listing on the exchange.
The listing provides a route for investors to access Injective tokens through familiar brokerage accounts. While this expands the types of digital assets available in exchange-traded formats, it introduces a layer of product structure and fees that distinguishes it from direct token ownership. The underlying market for Injective may differ in liquidity and investor base compared to larger cryptocurrencies like Bitcoin or Ether.
Investors considering the fund are advised to examine the prospectus for risks, fee structures, and precise mechanics. The potential for staking rewards should not be treated as a fixed interest payment, as the value delivered depends on various operational and market factors. The ETF’s trading record, including shares outstanding, assets under management, and bid-ask spreads, will provide further insight into its performance and liquidity post-launch.
Frequently Asked Questions
When did the Canary Staked INJ ETF start trading on Nasdaq?
The Canary Staked INJ ETF began trading on Nasdaq on November 5 under the ticker INJC, following a trader notice issued on November 4.
Does owning the INJC ETF allow investors to control their INJ tokens?
No, fund ownership is not the same as directly holding or controlling INJ in a self-custodied wallet. The ETF handles custody and operational choices, and investors cannot select validators or manage keys directly.
